Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids
Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral s...
Gespeichert in:
Veröffentlicht in: | BMJ 1969-07, Vol.3 (5664), p.195-200 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 200 |
---|---|
container_issue | 5664 |
container_start_page | 195 |
container_title | BMJ |
container_volume | 3 |
creator | Melamed, Myron R. Koss, Leopold G. Flehinger, Betty J. Kelisky, Richard P. Dubrow, Hilliard |
description | Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data. |
doi_str_mv | 10.1136/bmj.3.5664.195 |
format | Article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1984009</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>20377152</jstor_id><sourcerecordid>20377152</sourcerecordid><originalsourceid>FETCH-LOGICAL-b507t-3194a58057fd3751ad870b1ce76ef0090e24d6a64dcbe066bacfe4423aa633ca3</originalsourceid><addsrcrecordid>eNqFkc2P0zAQxS0EWqplr9yQLHHikGDHX8kFCWUXFrGwaNkCN8txJq1LExfbreC_x1WrAidOlvV78-ZpHkJPKSkpZfJlN65KVgopeUkb8QDNKJd1IWrGHqIZIUQVlHP1GF3EuMrfiqm6kfwMnQnVVJI0MxQ_BdiZNUwW8J1JELEf8DxBcBPgFsLOWbPGrQnWTX402E04urTFgw_4qx9hwvPopgVOS8CXzmyWwSxGnGHrpxSMhU1yO8C3Ibt8zrbe9fEJejSYdYSL43uO5m-u7tvr4ub27bv29U3RCaJSwWjDjaiJUEPPlKCmrxXpqAUlYSCkIVDxXhrJe9sBkbIzdgDOK2aMZMwado5eHXw3226E3sI-0VpvghtN-KW9cfpfMrmlXvidpk3N84Js8PxoEPyPLcSkV34bppxZU6Xy_QRtSFaVB5UNPsYAw2kDJXpfk841aab3NWVrkQee_Z3rJD-W8oevYvLhhCvClKKiyrw4cBcT_DxxE75rqfKl9McvrVbfPojLu_tr_T7rXxz0-xz_yfYbkom1pA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776095190</pqid></control><display><type>article</type><title>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>PubMed Central</source><creator>Melamed, Myron R. ; Koss, Leopold G. ; Flehinger, Betty J. ; Kelisky, Richard P. ; Dubrow, Hilliard</creator><creatorcontrib>Melamed, Myron R. ; Koss, Leopold G. ; Flehinger, Betty J. ; Kelisky, Richard P. ; Dubrow, Hilliard</creatorcontrib><description>Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.</description><identifier>ISSN: 0007-1447</identifier><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>DOI: 10.1136/bmj.3.5664.195</identifier><identifier>PMID: 5792609</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Adolescent ; Adult ; Age Factors ; Biopsies ; Birth control ; Carcinoma ; Carcinoma in situ ; Contraception ; Contraceptive Devices - adverse effects ; Contraceptives, Oral - adverse effects ; Cytology ; Estrogens - adverse effects ; Female ; Health Surveys ; Humans ; Middle Aged ; New York City ; Papers and Originals ; Parenthood ; Patient assessment ; Pregnancy ; Progestins - adverse effects ; Steroids ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - etiology ; Uterine Cervical Neoplasms - pathology ; Vaginal diaphragms</subject><ispartof>BMJ, 1969-07, Vol.3 (5664), p.195-200</ispartof><rights>Copyright 1969 British Medical Journal</rights><rights>Copyright BMJ Publishing Group LTD Jul 26, 1969</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b507t-3194a58057fd3751ad870b1ce76ef0090e24d6a64dcbe066bacfe4423aa633ca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/20377152$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/20377152$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,724,777,781,800,882,27905,27906,53772,53774,57998,58231</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5792609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melamed, Myron R.</creatorcontrib><creatorcontrib>Koss, Leopold G.</creatorcontrib><creatorcontrib>Flehinger, Betty J.</creatorcontrib><creatorcontrib>Kelisky, Richard P.</creatorcontrib><creatorcontrib>Dubrow, Hilliard</creatorcontrib><title>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</title><title>BMJ</title><addtitle>Br Med J</addtitle><description>Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Biopsies</subject><subject>Birth control</subject><subject>Carcinoma</subject><subject>Carcinoma in situ</subject><subject>Contraception</subject><subject>Contraceptive Devices - adverse effects</subject><subject>Contraceptives, Oral - adverse effects</subject><subject>Cytology</subject><subject>Estrogens - adverse effects</subject><subject>Female</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>New York City</subject><subject>Papers and Originals</subject><subject>Parenthood</subject><subject>Patient assessment</subject><subject>Pregnancy</subject><subject>Progestins - adverse effects</subject><subject>Steroids</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - etiology</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Vaginal diaphragms</subject><issn>0007-1447</issn><issn>0959-8138</issn><issn>1468-5833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1969</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkc2P0zAQxS0EWqplr9yQLHHikGDHX8kFCWUXFrGwaNkCN8txJq1LExfbreC_x1WrAidOlvV78-ZpHkJPKSkpZfJlN65KVgopeUkb8QDNKJd1IWrGHqIZIUQVlHP1GF3EuMrfiqm6kfwMnQnVVJI0MxQ_BdiZNUwW8J1JELEf8DxBcBPgFsLOWbPGrQnWTX402E04urTFgw_4qx9hwvPopgVOS8CXzmyWwSxGnGHrpxSMhU1yO8C3Ibt8zrbe9fEJejSYdYSL43uO5m-u7tvr4ub27bv29U3RCaJSwWjDjaiJUEPPlKCmrxXpqAUlYSCkIVDxXhrJe9sBkbIzdgDOK2aMZMwado5eHXw3226E3sI-0VpvghtN-KW9cfpfMrmlXvidpk3N84Js8PxoEPyPLcSkV34bppxZU6Xy_QRtSFaVB5UNPsYAw2kDJXpfk841aab3NWVrkQee_Z3rJD-W8oevYvLhhCvClKKiyrw4cBcT_DxxE75rqfKl9McvrVbfPojLu_tr_T7rXxz0-xz_yfYbkom1pA</recordid><startdate>19690726</startdate><enddate>19690726</enddate><creator>Melamed, Myron R.</creator><creator>Koss, Leopold G.</creator><creator>Flehinger, Betty J.</creator><creator>Kelisky, Richard P.</creator><creator>Dubrow, Hilliard</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>19690726</creationdate><title>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</title><author>Melamed, Myron R. ; Koss, Leopold G. ; Flehinger, Betty J. ; Kelisky, Richard P. ; Dubrow, Hilliard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b507t-3194a58057fd3751ad870b1ce76ef0090e24d6a64dcbe066bacfe4423aa633ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1969</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Biopsies</topic><topic>Birth control</topic><topic>Carcinoma</topic><topic>Carcinoma in situ</topic><topic>Contraception</topic><topic>Contraceptive Devices - adverse effects</topic><topic>Contraceptives, Oral - adverse effects</topic><topic>Cytology</topic><topic>Estrogens - adverse effects</topic><topic>Female</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>New York City</topic><topic>Papers and Originals</topic><topic>Parenthood</topic><topic>Patient assessment</topic><topic>Pregnancy</topic><topic>Progestins - adverse effects</topic><topic>Steroids</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - etiology</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Vaginal diaphragms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melamed, Myron R.</creatorcontrib><creatorcontrib>Koss, Leopold G.</creatorcontrib><creatorcontrib>Flehinger, Betty J.</creatorcontrib><creatorcontrib>Kelisky, Richard P.</creatorcontrib><creatorcontrib>Dubrow, Hilliard</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melamed, Myron R.</au><au>Koss, Leopold G.</au><au>Flehinger, Betty J.</au><au>Kelisky, Richard P.</au><au>Dubrow, Hilliard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</atitle><jtitle>BMJ</jtitle><addtitle>Br Med J</addtitle><date>1969-07-26</date><risdate>1969</risdate><volume>3</volume><issue>5664</issue><spage>195</spage><epage>200</epage><pages>195-200</pages><issn>0007-1447</issn><issn>0959-8138</issn><eissn>1468-5833</eissn><abstract>Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>5792609</pmid><doi>10.1136/bmj.3.5664.195</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1447 |
ispartof | BMJ, 1969-07, Vol.3 (5664), p.195-200 |
issn | 0007-1447 0959-8138 1468-5833 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1984009 |
source | MEDLINE; Jstor Complete Legacy; PubMed Central |
subjects | Adolescent Adult Age Factors Biopsies Birth control Carcinoma Carcinoma in situ Contraception Contraceptive Devices - adverse effects Contraceptives, Oral - adverse effects Cytology Estrogens - adverse effects Female Health Surveys Humans Middle Aged New York City Papers and Originals Parenthood Patient assessment Pregnancy Progestins - adverse effects Steroids Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - etiology Uterine Cervical Neoplasms - pathology Vaginal diaphragms |
title | Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T22%3A48%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20Rates%20of%20Uterine%20Cervical%20Carcinoma%20in%20situ%20for%20Women%20Using%20the%20Diaphragm%20or%20Contraceptive%20Oral%20Steroids&rft.jtitle=BMJ&rft.au=Melamed,%20Myron%20R.&rft.date=1969-07-26&rft.volume=3&rft.issue=5664&rft.spage=195&rft.epage=200&rft.pages=195-200&rft.issn=0007-1447&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.3.5664.195&rft_dat=%3Cjstor_pubme%3E20377152%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776095190&rft_id=info:pmid/5792609&rft_jstor_id=20377152&rfr_iscdi=true |